Lymph node size as a simple prognostic factor in node negative colon cancer and an alternative thesis to stage migration

被引:26
作者
Maerkl, Bruno [1 ]
Schaller, Tina [1 ]
Kokot, Yuriy [2 ]
Endhardt, Katharina [1 ]
Kretsinger, Hallie [1 ]
Hirschbu, Klaus [3 ]
Aumann, Georg [4 ]
Schenkirsch, Gerhard [5 ]
机构
[1] Klinikum Augsburg, Inst Pathol, Augsburg, Germany
[2] Klinikum Augsburg, Med Clin 4, Augsburg, Germany
[3] Klinikum Augsburg, Med Clin 2, Augsburg, Germany
[4] Klinikum Augsburg, Dept Visceral & Transplantat Surg, Augsburg, Germany
[5] Klinikum Augsburg, Clin & Populat Based Canc Registry Augsburg, Augsburg, Germany
关键词
Colon cancer; Lymph node; Immune response; Size; Stage migration; II COLORECTAL-CANCER; SURVIVAL; NUMBER; RESECTION; DISSECTION; SPECIMENS; QUALITY; HARVEST;
D O I
10.1016/j.amjsurg.2015.05.026
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Stage migration is an accepted explanation for the association between lymph node (LN) yield and outcome in colon cancer. To investigate whether the alternative thesis of immune response is more likely, we performed a retrospective study. METHODS: We enrolled 239 cases of node negative cancers, which were categorized according to the number of LNs with diameters larger than 5 mm (LN5) into the groups LN5-very low (0 to 1 LN5), LN5-low (2 to 5 LN5), and LN5-high (>= 6 LN5). RESULTS: Significant differences were found in pT3/4 cancers with median survival times of 40, 57, and 71 months (P = .022) in the LN5-very low, LN5-low, and LN5-high groups, respectively. Multi-variable analysis revealed that LN5 number and infiltration type were independent prognostic factors. CONCLUSIONS: LN size is prognostic in node negative colon cancer. The correct explanation for outcome differences associated with LN harvest is probably the activation status of LNs. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:775 / 780
页数:6
相关论文
共 33 条
  • [1] Lymph node count and prognosis in colorectal cancer: The influence of examination quality
    Blaeker, Hendrik
    Hildebrandt, Bert
    Riess, Hanno
    von Winterfeld, Moritz
    Ingold-Heppner, Barbara
    Roth, Wilfried
    Kloor, Matthias
    Schirmacher, Peter
    Dietel, Manfred
    Tao, Sha
    Jansen, Lina
    Chang-Claude, Jenny
    Ulrich, Alexis
    Brenner, Hermann
    Hoffmeister, Michael
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (08) : 1957 - 1966
  • [2] Lymph node evaluation and survival after curative resection of colon cancer: Systematic review
    Chang, George J.
    Rodriguez-Bigas, Miguel A.
    Skibber, John M.
    Moyer, Virginia A.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06) : 433 - 441
  • [3] Does Reevaluation of Colorectal Cancers With Inadequate Nodal Yield Lead to Stage Migration or the Identification of Metastatic Lymph Nodes?
    Chen, Lilian
    Kalady, Matthew F.
    Goldblum, John
    Seyidova-Khoshknabi, Dilara
    Burks, Eric J.
    Roberts, Patricia L.
    Ricciardi, Rocco
    [J]. DISEASES OF THE COLON & RECTUM, 2014, 57 (04) : 432 - 437
  • [4] The number of analyzed lymph nodes -: a prognostic factor in colorectal cancer
    Edler, David
    Ohrling, Katarina
    Hallstrom, Marja
    Karlberg, Mia
    Ragnhammar, Peter
    [J]. ACTA ONCOLOGICA, 2007, 46 (07) : 975 - 981
  • [5] THE ROGERS,WILL PHENOMENON - STAGE MIGRATION AND NEW DIAGNOSTIC-TECHNIQUES AS A SOURCE OF MISLEADING STATISTICS FOR SURVIVAL IN CANCER
    FEINSTEIN, AR
    SOSIN, DM
    WELLS, CK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) : 1604 - 1608
  • [6] Adjuvant therapy for completely resected stage II colon cancer
    Figueredo, Alvaro
    Coombes, Megan E.
    Mukherjee, Som
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [7] Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists
    George, S.
    Primrose, J.
    Talbot, R.
    Smith, J.
    Mullee, M.
    Bailey, D.
    du Boulay, C.
    Jordan, H.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 841 - 847
  • [8] Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much?
    Gill, S
    Loprinzi, CL
    Sargent, DJ
    Thomé, SD
    Alberts, SR
    Haller, DG
    Benedetti, J
    Francini, G
    Shepherd, LE
    Seitz, JF
    Labianca, R
    Chen, W
    Cha, SS
    Heldebrant, MP
    Goldberg, RM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1797 - 1806
  • [9] Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years - Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities
    Goldstein, NS
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (02) : 179 - 189
  • [10] Stage II colorectal cancer: To treat or not to treat
    Johnston, PG
    [J]. ONCOLOGIST, 2005, 10 (05) : 332 - 334